% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • biotechbeagle biotechbeagle Jul 19, 2013 11:03 AM Flag

    Biotech run-up on ONXX and ALXN Acquisition news, Reuters article pouring ice the the valuation frenzy

    I was glad to see IMGN was not one of the biotechs seen as running up based on potential acquisition. Our valuation is based on Kadcyla Sales potential and pipeline advances. SGEN was the only one highlighted as rational at this point.

    Sentiment: Buy

2.78-0.03(-1.07%)Jul 26 4:00 PMEDT